Derecho ambiental
In therapeutic research and development, achieving a thorough understanding of disease mechanisms, target engagement, and treatment response is critical. This complexity is particularly evident in oncology and cell-based therapies, where genetic alterations, transcript variations, and immune signaling within tissue microenvironments are pivotal. Traditional analytical methods frequently overlook these nuanced aspects, but techniques like In Situ Hybridization (ISH) and Fluorescence In Situ Hybridization (FISH) provide the necessary tools for the detailed investigation of these dynamics.
The Role of ISH and FISH
ISH and FISH methodologies enable the visualization of genes, RNA transcripts, immune mediators, and engineered or transplanted cells at both cellular and tissue levels. These techniques allow for spatially resolved molecular analysis that is essential in various biological contexts, such as tumor tissues, circulating tumor cells (CTCs), and preclinical models. By providing spatial context, these methods enhance target validation, elucidate mechanisms of action, and guide decision-making throughout the drug development pipeline.
Range of Services Offered
Creative Bioarray specializes in a variety of ISH and FISH analysis services designed to support therapeutic research:
Neoplasms FISH Analysis: This service offers precise identification of gene amplifications, deletions, or translocations in tumor samples to inform prognosis and companion diagnostics.
Circulating Tumor Cell (CTC) FISH: This analysis addresses the challenges presented by rare CTCs and permits liquid biopsy studies to investigate tumor heterogeneity and disease progression.
In Situ Detection of Chemokines/Cytokines: This service enables the detailed examination of immune signaling molecules, which is vital in evaluating inflammatory responses in the tumor microenvironment.
In Situ Detection of CAR-T Cells & Oncolytic Viruses: By analyzing the localization and persistence of engineered immune cells and viral vectors in tissue sections, researchers can better understand biodistribution and therapeutic mechanisms.
CAR-T/CAR-NK Target Assessment (ISH): This offers insights at the RNA level regarding target antigen expression, aiding assessments of availability and therapeutic viability.
Mouse Model and PDX Analysis (FISH): Supports the chromosomal and molecular characterization of tumors within both mouse models and patient-derived xenografts, enhancing preclinical oncology research.
Cell Transplantation Analysis (FISH): Enables tracking of transplanted cells’ survival and integration into host tissues, critical for evaluating cell therapy outcomes.
Why Partner with Creative Bioarray?
Creative Bioarray brings valuable advantages to your research efforts:
Spatial Resolution: Our approach allows for visualization of gene and RNA expression within tissue sections, providing essential context that complements traditional bulk assays.
Expertise in Probe Design and Validation: Our experienced bioinformatics team offers customized probe design and validation services, ensuring specificity across key targets relevant to cancer and cell therapy.
Strong Translational Experience: We leverage our extensive experience from successful preclinical development programs for CAR-T, oncolytic viruses, and small molecules to inform best practices in translational research.
Diverse Sample Handling Capabilities: We are adept at processing a variety of challenging biological samples, including FFPE tissue, fresh/frozen tissues, blood CTCs, and more, thus accommodating diverse experimental needs.
Applications Throughout the Development Pipeline
The integration of ISH and FISH techniques throughout the therapeutic development pipeline enables nuanced insights and supports effective decision-making across research stages. For more information on our ISH/FISH analysis services, please visit our website and explore the full array of offerings.